Revox B77
Revox B77 Just Exfoliating Toner 250 ml Glycolic Acid
Revox B77 Just Exfoliating Toner 250ml with Glycolic Acid is a high-quality product designed for discerning individuals who care about their appearance and seek the best cosmetics to enhance their beauty. If you are one of them, 100% genuine Revox B77 products are made for you.
Just's Exfoliating Toner from Revox B77 is a cosmetic product designed for facial care. It stands out for its 7% glycolic acid formulation, ideal for improving skin texture through its gentle yet effective exfoliating action. Presented in a 250ml bottle , this liquid toner is suitable for both day and night use, adapting to any user's daily routine. Its formula is suitable for all skin types , making it a versatile and accessible option. It offers an experience that can be enjoyed by both women and is unisex , guaranteeing appropriate and balanced care for diverse needs. Although it does not contain sunscreen, its regular use contributes to cell renewal and the elimination of impurities, leaving the skin brighter and smoother. This product falls within the facial cosmetics category, where the effectiveness of exfoliating acids is valued for promoting a healthy and revitalized appearance. Made in the UK, the Revox B77 Just toner combines quality and functionality in a convenient format for easy integration into your daily skincare routine. It's a reliable solution for those seeking an effective, skin-friendly exfoliating treatment suitable for continuous use by both women and men.
- Type: Cosmetics
- Ingredients:
- Glycolic acid
- Potassium hydroxide
- Propylene glycol
- Sodium hyaluronate
- Urea
- Collagen
- Glycolic acid
- Phenoxyethanol
- Properties:
- Illuminator
- Softener
- Exfoliating
- Refreshing
- Features: Two-phase
- Gender: Unisex
- Texture: Liquid
- Recommended use: All skin types
- Capacity: 250 ml
General Product Safety Regulations information:
Revox
Industriestrasse 11, Regensdorf, Switzerland, 8105
8105 - Regensdorf
+41448707111
info@revoxb77.com
https://www.revox.com


